Hi Tech Pharmacal Co. Inc. (HITK)

Sentiment: Bullish

Awesome small cap company. Undervalued compared to it's peers. Great blance sheet. Low p/e. Consistently beats estimates.

Background:
Hi-Tech Pharmacal Co., Inc. develops, manufactures, markets, and sells generic, prescription, over-the-counter (OTC), and nutritional products in liquid and semisolid dosage forms in the United States. It produces a range of products for various disease states, including asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care, neurological disorders, glaucoma, and other conditions. The company’s generic pharmaceutical products include oral solutions and suspensions, topical creams and ointments, and nasal sprays. Hi-Tech Pharmacal Co. also manufactures and sells liquid ophthalmic, otic, and inhalation products, as well as cough and cold products and prescription vitamins. It markets a line of branded products that include OTC, nutritional lines, and prescription products primarily for people with diabetes. The company’s product line comprises Diabetic Tussin for the treatment of cough; Zostrix for pain relief; DiabetiDerm, a dermatological and footcare product line; Multibetic, a multivitamin product; DiabetiSweet, a sugar substitute; Nasal Ease for allergy relief; and Mag-Ox line of magnesium nutritional supplements. It offers its products to chain drug stores, drug wholesalers, managed care purchasing organizations, certain Federal government agencies, generic distributors, mass merchandisers, and mail-order pharmacies. The company was founded in 1982 and is based in Amityville, New York.

Look for stock to move to 30 within 3 months